🔓
Sign in as a Member to unlock the full view of EMBC. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
EMBC

Embecta Corp.

Sector: healthcareDrug Manufacturers - Specialty & GenericNASDAQMarket Cap: $635.4M

Embecta is a medical-device company focused on diabetes management and injection systems with minimal direct government dependence and low political profile.

Next filing → your inbox
Govt Dependence
15/100
Regulatory Density
45/100
Lobbying Intensity
5/100
Political Signal
LOW

BusinessWhat EMBC does

Embecta manufactures and distributes diabetes care devices, including pen needles, syringes, and infusion sets. Revenue is primarily driven by direct sales to healthcare providers, pharmacies, and patients in the US and international markets. The company has no material government contracts or Medicare/Medicaid rate dependence.

Executive Branch ConflictsEMBC held by Trump-administration officials

Lifetime Government AwardsEMBC federal contracts

EMBC doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding EMBC

$7.3M
Total EMBC held by tracked 13F funds
5
Funds with EMBC positions
+2
Funds opened this quarter
AQR Capital Management $3M +195% 2026-06-30
D.E. Shaw & Co. $2M +22% 2026-06-30
Citadel Advisors $2M +10% 2026-06-30
Renaissance Technologies $443K opened 2026-09-30
Point72 Asset Management $66K opened 2026-06-30

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Open-market buys

A
Insider signal score 70/100 · 4 distinct insiders · 4 open-market buys totaling $558K in the last 180 days.
2026-08-12 HOMBACH ROBERT J. BUY 45,000 sh $224K

Bills Affecting EMBCLive legislation impacting this stock

Political ProfileWhere EMBC sits in Washington

Embecta has no measurable lobbying footprint, zero politician trades, and no named legislative winners/losers. Stock movement is driven by clinical efficacy, reimbursement rates, and competitive dynamics rather than federal policy.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • FDA reimbursement pressure
  • state-level diabetes-supply price caps

Regulatory opportunities

  • FDA 510(k) pathway streamlining
  • Medicare coverage expansion for diabetes devices
Member intelligence layer

Live signals + predictions for EMBC — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout EMBC & political exposure

Does Embecta Corp. (EMBC) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Embecta Corp.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Which Trump cabinet officials own EMBC stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in EMBC on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
What is EMBC political risk profile?
Government dependence: 15/100. Lobbying intensity: 5/100. Political signal: low.
How does GovGreed track EMBC political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. EMBC data is updated daily from these official federal sources.